760
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Neuroprotection by herbal formula FBD and its active compounds

, , &
Pages 608-614 | Received 03 Feb 2008, Accepted 19 Jun 2008, Published online: 22 Jun 2009

References

  • Adams M, Gmünder F, Hamburger M (2007): Plants traditionally used in age related brain disorders–A survey of ethnobotanical literature. J Ethnopharmacol 113: 363–381.
  • Cao LL, Du GH, Wang MW (2006): The effect of salidroside on cell damage induced by glutamate and intracellular free calcium in PC12 cells. J Asian Nat Prod Res 8: 159–165.
  • Cao Y, Zhu DN, Lin ZH, Xiao ZB, Yan YQ, Yu BY (2007): Serum pharmacochemistry of FBD (I). J China Pharm Univ 38: 519–522.
  • Cho KO, Kim SK, Cho YJ, Sung KW, Kim SY (2007): Regional differences in the neuroprotective effect of minocycline in a mouse model of global forebrain ischemia. Life Sci 80: 2030–2035.
  • Cuella MJ, Giner RM, Recio MC, Just MJ, Manez S, Rios JL (1996): Two fungal lanostane derivatives as phospholipase A2 inhibitors. J Nat Prod 59: 977–979.
  • Dong WX, Ruan KF, Gu FH, Shen PN, Li PY, Lin ZH (2006): FBD used to improve learning and memory function of animals. Chin Trad Herbal Drugs 37: 1831–1835.
  • Gapter L, Wang Z, Glinski J, Ng KY (2005): Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun 332: 1153–1161.
  • Giner Larza EM, Manez S, Giner Pons RM, Recio MC, Rios JL (2000): On the anti-inflammatory and anti-phospholipase A-2 activity of extracts from lanostane-rich species. J Ethnopharmacol 73: 61–69.
  • Giner EM, Manez S, Recio MC, Giner RM, Cerda-Nicolas M, Rios JL (2000): In vivo studies on the anti-inflammatory activity of pachymic and dehydrotumulosic acids. Planta Med 66: 221–227.
  • Goldshmidt Y, Erlich S, Pinkas-Kramarski R(2001): Neuregulin rescue PC12-ErbB4 cells from cell death induced by H2O2: Regulation of reactive oxygen species levels by PI3K. J Biol Chem 276: 46379–46385.
  • Gong X, Sucher NJ (1999): Stroke therapy in traditional Chinese medicine (TCM): Prospects for drug discovery and development. TiPS 20: 191–196.
  • Jin Y, Yan EZ, Fan Y, Zong ZH, Qi ZM, Li Z (2005): Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol Sin 26: 943–951.
  • Kaminaga T, Yasukawa K, Kanno H, Tai T, Nunoura Y, Takido M (1996): Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O- tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 53: 382–385.
  • Kanski J, Aksenova M, Stoyanova A, Butterfield DA (2002): Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure-activity studies. J Nutr Biochem 3: 273–281.
  • Ko WC, Sheu JR, Leu YR, Tzeng SH, Chen CM (1997): Stereoselectivity of butylidenephthalide on voltage-dependent calcium channels in guinea-pig isolated ileum. J Pharm Pharmacol 49: 1121–1125.
  • Kuang X, Yao Y, Du JR, Liu YX, Wang CY, Qian ZM (2006): Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res 1102: 145–153.
  • Li CQ, He LC, Jin JQ (2007): Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother Res 21: 347–353.
  • Li G, Xu ML, Lee CS, Woo MH, Chang HW, Son JK (2004): Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch Pharm Res 27: 829–833.
  • Lin LZ, He XG, Lian LZ, King W, Elliott J (1998): Liquid chromatographic–electrospray mass spectrometric study of the phthalides of Angelica sinensis and chemical changes of Z-ligustilide. J Chromatogr A 810: 71–79.
  • Lin Z, Zhu D, Yan Y, Yu B, Wang Q (2005): Protective effects of FBD–an experimental Chinese traditional medicinal formula on memory dysfunction in mice induced by cerebral ischemia-reperfusion. J Ethnopharmacol 97: 477–483.
  • Liu J, Lin ZH, Yu BY, Zhu DN, Yan YQ (2007): Study X on substance basis and mechanism of action of Danggui Shaoyao San in the prevention and treatment of senile dementia–Protective effect of FBD and CO2 supercritical fluid extract (P2) on astrocyte anoxic injury. Chin J Exp Trad Med Formul 13: 14–17.
  • Liu YM, Zhang JJ, Jiang J, Huang CY, Ren SL, Gao YZ (2004): Observation on clinical effect of Angelica injection in treating acute cerebral infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 24: 205–208.
  • Luo L, Zhu DN, Yan YQ (2005): SFE-CO2 constituents of simplified formula of Danggui Shaoyao powder in the prevention and treatment of vascular dementia. Chin Tradit Patent Med 27: 1251–1254.
  • Ogiwara T, Satoh K, Kadoma Y, Murakami Y, Unten S, Atsumi T, Sakagami H, Fujisawa S (2002): Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 22: 2711–2717.
  • Sekiya N, Goto H, Shimada Y, Endo Y, Sakakibara I, Terasawa K (2003): Inhibitory effects of triterpenes isolated from Hoelen on free radical-induced lysis of red blood cells. Phytother Res 17: 160–162.
  • Wang P, Yu BY, Lin ZH, Yan YQ (2004): Study on basis and mechanism of action of optimized Danggui Shaoyao San in the improvement effect on learning and memory impairment in mice. Chin J Exp Trad Med Formul 10: 18–21.
  • Wang R, Wang GJ, Hao HP, Xie HT, Zhang JF, Wu F (2006): Quantitative determination of atractylenolide III in rat plasma by LC-ESI-MS. J Chromatogr B 831: 36–41.
  • Wang YL, Liang YZ, Chen BM, He YK, Li BY, Hu QN (2005): LC-DAD-APCI-MS-based screening and analysis of the absorption and metabolite components in plasma from a rabbit administered an oral solution of danggui. Anal Bioanal Chem 383: 247–254.
  • Wang Z, Gao YH, Huang RS, Zhu GQ (1988): Sodium ferulate is an inhibitor of thromboxane A2 synthetase. Acta Pharmacol Sin 9: 430–433.
  • Watanabe Y, Zhang XQ, Liu JS, Guo Z, Ohnishi M, Shibuya T (1995): Protection of glutamate induced neuronal damages in cultured cerebella granule cells by Chinese herbal medicine, Toki-shakuyaku-san and its comprised six medicinal herbs. J Tradit Med 12: 93–101.
  • Wu F, Zhu DN, Lin ZH, Yan YQ (2007): Study on material basis and mechanism of action of Danggui Shaoyao San in the prevention and treatment of senile dementia IX: The anti-oxidative activity of the polysaccharides of FBD. Chin J Exp Trad Med Formul 13: 23–26.
  • Xu HL, Feng YP (2000): Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol Sin 21: 433–438.
  • Yan B, Bi X, He J, Zhang Y, Thakur S, Xu H, Gendron A, Kong J, Li XM (2007): Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice. Life Sci 81: 353–361.
  • Yu L, Zhang Y, Ma R, Bao L, Fang J, Yu T (2006): Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Eur Neuropsychopharmacol 16: 170–177.
  • Zhang QC, Wang QJ, Kou JP, Zhu DN, Yan YQ, Yu BY (2005): Protective effect of cerebrospinal fluids containing optimized Danggui-shaoyao-san (FBD) on injured PC12 cells. Chin J Exp Trad Med Formul 11: 55–58.
  • Zhang YQ, Xu SB, Lin YC, Li Q, Zhang X, Lai YR (2000): Antagonistic effects of 3 sesquiterpene lactones from Atractylodes macrocephala Koidz on rat uterine contraction in vitro. Acta Pharmacol Sin 21: 91–96.
  • Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W (2003): Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur J Pharmacol 467: 41–47.
  • Zhen G, Doré S (2007): Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice. J Neurosci Methods 166: 73–80.
  • Zhou SN, Wang QJ, Zhu DN (2006): The effect of optimized Danggui Shaoyao San (FBD) on cerebral ischemia reperfusion. Chin J Exp Trad Med Formul 12: 47–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.